TREM2, a diagnostic and therapeutic target for Alzheimer's disease TREM2, a diagnostic and therapeutic target for Alzheimer's disease

 You need your doctor to understand and follow this research.

Your risk of dementia, has your doctor told you of this?

1. A documented 33% dementia chance post-stroke from an Australian study?   May 2012.

2. Then this study came out and seems to have a range from 17-66%. December 2013.`    

3. A 20% chance in this research.   July 2013.

4. Dementia Risk Doubled in Patients Following Stroke September 2018 

What is your doctor's EXACT PROTOCOL TO PREVENT DEMENTIA?

The latest here:

Find out more

 Consistently, studies have shown that TREM2 plays a protective role in the pathological process of Alzheimer's disease (AD) by promoting the clearance of tissue debris and the resolution of underlying inflammatory responses while maintaining immune homeostasis in the brain. The observed changes in sTREM2 levels underscore the importance of TREM2 in human neurological disorders and the exciting possibilities of TREM2 as a diagnostic and therapeutic target. ACROBiosystems is providing you a series of high-quality TREM2 proteins to facilitate your research programs.